tiprankstipranks
Arch Biopartners (TSE:ARCH)
TSXV:ARCH
Canadian Market
Holding TSE:ARCH?
Track your performance easily

Arch Biopartners (ARCH) Financial Statements

17 Followers

Arch Biopartners Financial Overview

Arch Biopartners's market cap is currently ―. The company's EPS TTM is C$-0.041; its P/E ratio is -43.17; Arch Biopartners is scheduled to report earnings on February 4, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-C$ 2.18M-C$ -1.10MC$ 116.37K
Gross Profit-C$ 2.18MC$ 298.14KC$ -1.10MC$ 116.37K
EBITC$ -829.20KC$ -1.06MC$ -694.55KC$ 359.92KC$ -642.65K
EBITDAC$ -829.20KC$ -1.06MC$ -694.55KC$ 359.92KC$ -642.65K
Net Income Common StockholdersC$ -884.57KC$ -1.15MC$ -783.25KC$ 244.28KC$ -704.07K
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 43.95KC$ 6.56KC$ 302.63KC$ 831.27KC$ 1.40M
Total AssetsC$ 1.54MC$ 1.79MC$ 636.48KC$ 1.17MC$ 1.42M
Total DebtC$ 5.31MC$ 4.96MC$ 5.04MC$ 4.81MC$ 4.77M
Net DebtC$ 5.27MC$ 4.95MC$ 4.73MC$ 3.98MC$ 3.37M
Total LiabilitiesC$ 8.10MC$ 8.22MC$ 6.35MC$ 6.68MC$ 7.17M
Stockholders EquityC$ -6.56MC$ -6.44MC$ -5.71MC$ -5.51MC$ -5.75M
Cash Flow-
Free Cash FlowC$ -864.11KC$ -511.57KC$ -546.34KC$ 443.13KC$ 567.65K
Operating Cash FlowC$ -864.11KC$ -511.57KC$ -546.34KC$ 443.13KC$ 567.65K
Investing Cash Flow---C$ 1.35MC$ -1.35M
Financing Cash FlowC$ 901.50KC$ 215.50KC$ 17.70KC$ -1.01MC$ 121.00K
Currency in CAD

Arch Biopartners Earnings and Revenue History

Arch Biopartners Debt to Assets

Arch Biopartners Cash Flow

Arch Biopartners Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis